SCHEMBL9934401

SCHEMBL9934401

c1ccc(N(c2ccccc2)c2ccccc2)cc1.c1ccc2c(N(c3cccc4ccccc34)c3cccc4ccccc34)cccc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 9/20 0.50
ALDH1A1 P00352 4/20 0.41
CYP1A2 P05177 4/20 0.41
CYP3A4 P08684 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
CYP2D6 P10635 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 1/20 0.41
CYP2A6 P11509 3/20 0.40
TSHR P16473 2/20 0.40
HSD17B10 Q99714 2/20 0.40
HPGD P15428 1/20 0.38
KEAP1 Q14145 1/20 0.38
NR4A1 P22736 1/20 0.38
NR4A2 P43354 1/20 0.38
NR4A3 Q92570 1/20 0.38
HPRT1 P00492 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12119474 0.94 SIGMAR1 (0.49) SIGMAR1ALDH1A1CYP1A2CYP3A4L3MBTL1
SCHEMBL13721259 0.94 SIGMAR1 (0.49) SIGMAR1ALDH1A1CYP1A2CYP3A4L3MBTL1
SCHEMBL13720492 0.94 SIGMAR1 (0.49) SIGMAR1ALDH1A1CYP1A2CYP3A4L3MBTL1
SCHEMBL13020775 0.94 SIGMAR1 (0.49) SIGMAR1ALDH1A1CYP1A2CYP3A4L3MBTL1
SCHEMBL4581137 0.94 SIGMAR1 (0.49) SIGMAR1ALDH1A1CYP1A2CYP3A4L3MBTL1
SCHEMBL13721110 0.94 SIGMAR1 (0.49) SIGMAR1ALDH1A1CYP1A2CYP3A4L3MBTL1
SCHEMBL13721438 0.94 SIGMAR1 (0.49) SIGMAR1ALDH1A1CYP1A2CYP3A4L3MBTL1
SCHEMBL13720498 0.94 SIGMAR1 (0.49) SIGMAR1ALDH1A1CYP1A2CYP3A4L3MBTL1
SCHEMBL13720893 0.94 SIGMAR1 (0.49) SIGMAR1ALDH1A1CYP1A2CYP3A4L3MBTL1
SCHEMBL12636587 0.94 SIGMAR1 (0.49) SIGMAR1ALDH1A1CYP1A2CYP3A4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120157680-A1 IONIC LIQUID CONTAINING ALLYLSULFONATE ANION WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) 2012-06-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157680-A1 IONIC LIQUID CONTAINING ALLYLSULFONATE ANION ATXN2L, ARL1, INPPL1 SIGMAR1 413/4885ALDH1A1 3717/4885CYP1A2 4011/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.